For now, gastric cancer is a group of diseases and thus is being treated as such. Thus, for some patients with gastric cancer, information about biomarkers is taken into account in addition to the conventional treatment using surgery, chemotherapy and radiation. The goal is to select the most appropriate targeted therapy or immunotherapy for individual patients.
Biomarker-driven care utilizes a multitude of information regarding a patient’s tumor and the cancer
